BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
3.680
+0.335 (10.01%)
At close: Aug 20, 2026, 4:00 PM EDT
3.770
+0.090 (2.44%)
After-hours: Aug 20, 2026, 4:50 PM EDT

BioStem Technologies Revenue

BioStem Technologies had revenue of $7.90M in the quarter ending June 30, 2026, a decrease of -27.95%. This brings the company's revenue in the last twelve months to $34.59M, down -49.13% year-over-year. In the year 2025, BioStem Technologies had annual revenue of $47.48M, down -31.84%.

Revenue (ttm)
$34.59M
Revenue Growth
-49.13%
P/S Ratio
1.73
Revenue / Employee
$473,789
Employees
73
Market Cap
65.69M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.48M-22.18M-31.84%
Dec 31, 202469.66M52.97M317.48%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Apollomics8.84M
TScan Therapeutics7.11M
Immutep5.28M
Alps Group3.74M
RenovoRx1.98M
aTyr Pharma190.00K
Impact BioMedical35.00K
eXoZymes-700.00
Revenue Rankings